Sign in

CIK 0001237831 · Large accelerated filer

GLOBUS MEDICAL INC

Sign in to watch
Ticker
GMED
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
043744954
Phone
610-930-1800
Business address
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA, 19403
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$7,970,014
in 4 filings, $425K under 10b5-1 plans

Net −$7,970,014. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-05 Davidar David D Director Option exercise · Stock Option (Right to Buy Class A Common Stock) −25,000 0
2026-06-04 RHOADS ANN D Director Option exercise +25,000 $26.27 $657K 40,384
2026-06-04 RHOADS ANN D Director Option exercise · Stock Option (Right to Buy Class A Common Stock) −25,000 0
2026-02-25 Huller Kelly EVP, GC, Corporate Secretary Option exercise 10b5-1 +20,000 $43.58 $872K 20,000
2026-02-25 Huller Kelly EVP, GC, Corporate Secretary Sale 10b5-1 −20,000 $94.50 $1.9M 0
2026-02-25 Huller Kelly EVP, GC, Corporate Secretary Option exercise · Stock Option (Right to Buy Class A Common Stock) 10b5-1 −20,000 20,000
2026-02-12 Huller Kelly EVP, GC, Corporate Secretary Option exercise 10b5-1 +10,000 $45.64 $456K 10,000
2026-02-12 Huller Kelly EVP, GC, Corporate Secretary Sale 10b5-1 −10,000 $87.67 $877K 0
2026-02-12 Huller Kelly EVP, GC, Corporate Secretary Option exercise · Stock Option (Right to Buy Class A Common Stock) 10b5-1 −10,000 0
2026-01-21 Norwalk Leslie V Director Grant or award · Stock Option (Right to Buy Class A Common Stock) +15,000 15,000
2026-01-21 Pfeil Keith W President, CEO Grant or award · Stock Option (Right to Buy Class A Common Stock) +100,000 100,000
2026-01-21 Kline Kyle Senior Vice President, CFO Grant or award · Stock Option (Right to Buy Class A Common Stock) +30,000 30,000
2026-01-21 Paul David C Executive Chairman Grant or award · Stock Option (Right to Buy Class A Common Stock) +100,000 100,000
2026-01-21 Douglas Robert Andrew Director Grant or award · Stock Option (Right to Buy Class A Common Stock) +15,000 15,000
2026-01-21 Lemaitre Dan Director Grant or award · Stock Option (Right to Buy Class A Common Stock) +15,000 15,000
2026-01-21 RHOADS ANN D Director Grant or award · Stock Option (Right to Buy Class A Common Stock) +15,000 15,000
2026-01-21 TOBIN JAMES R Director Grant or award · Stock Option (Right to Buy Class A Common Stock) +15,000 15,000
2026-01-21 ZARRILLI STEPHEN T Director Grant or award · Stock Option (Right to Buy Class A Common Stock) +15,000 15,000
2026-01-21 DeFord John A Director Grant or award · Stock Option (Right to Buy Class A Common Stock) +15,000 15,000
2026-01-21 Wolterman Dan Director Grant or award · Stock Option (Right to Buy Class A Common Stock) +15,000 15,000

Page 2 of 10 · 200 trades